These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3069731)

  • 21. Role of c-myc and other genes in interleukin 2 regulated CT6 T lymphocytes and their malignant variants.
    Cleveland JL; Rapp UR; Farrar WL
    J Immunol; 1987 May; 138(10):3495-504. PubMed ID: 3106484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A transcriptional arrest mechanism involved in controlling constitutive levels of mouse c-myb mRNA.
    Watson RJ
    Oncogene; 1988 Mar; 2(3):267-72. PubMed ID: 3281094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcription of the c-myc oncogene is altered in spontaneously immortalized rodent fibroblasts.
    Tavassoli M; Shall S
    Oncogene; 1988 Apr; 2(4):337-45. PubMed ID: 3283652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-myc proto-oncogene expression can induce DNA replication in Balb/c 3T3 fibroblasts.
    Cavalieri F; Goldfarb M
    Oncogene; 1988 Mar; 2(3):289-91. PubMed ID: 3281096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell growth suppression by thanatos-associated protein 11(THAP11) is mediated by transcriptional downregulation of c-Myc.
    Zhu CY; Li CY; Li Y; Zhan YQ; Li YH; Xu CW; Xu WX; Sun HB; Yang XM
    Cell Death Differ; 2009 Mar; 16(3):395-405. PubMed ID: 19008924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. hTERT promoter induces tumor-specific Bax gene expression and cell killing in syngenic mouse tumor model and prevents systemic toxicity.
    Gu J; Andreeff M; Roth JA; Fang B
    Gene Ther; 2002 Jan; 9(1):30-7. PubMed ID: 11850720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenobarbital causes apoptosis in conditionally immortalized mouse hepatocytes depending on deregulated c-myc expression: characterization of an unexpected effect.
    Osanai M; Ogawa K; Lee GH
    Cancer Res; 1997 Jul; 57(14):2896-903. PubMed ID: 9230198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure and activity of the translocated c-myc in mouse plasmacytoma XRPC-24.
    Moav B; Horowitz M; Cohen JB; Rechavi G; Eliyahu E; Oren M; Givol D
    Gene; 1986; 48(2-3):297-300. PubMed ID: 3549466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opposite transcriptional activity between the wild type c-myc gene coding for c-Myc1 and c-Myc2 proteins and c-Myc1 and c-Myc2 separately.
    Batsché E; Crémisi C
    Oncogene; 1999 Oct; 18(41):5662-71. PubMed ID: 10523846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Re-transformation of non-transformed hybrids between c-myc-activating mouse plasmacytoma cells and normal fibroblasts by transfection with activated c-Ha-ras but not c-myc.
    Satoh C; Oikawa T; Kondoh N; Kuzumaki N
    Int J Cancer; 1991 Sep; 49(3):403-8. PubMed ID: 1917139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. c-Myc induces the expression and activity of ornithine decarboxylase.
    Wagner AJ; Meyers C; Laimins LA; Hay N
    Cell Growth Differ; 1993 Nov; 4(11):879-83. PubMed ID: 8297793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncogene-mediated multistep transformation of C3H10T1/2 cells.
    Taparowsky EJ; Heaney ML; Parsons JT
    Cancer Res; 1987 Aug; 47(15):4125-9. PubMed ID: 3300959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of reactive oxygen species, DNA damage, and c-Myc function by peroxiredoxin 1.
    Egler RA; Fernandes E; Rothermund K; Sereika S; de Souza-Pinto N; Jaruga P; Dizdaroglu M; Prochownik EV
    Oncogene; 2005 Dec; 24(54):8038-50. PubMed ID: 16170382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defective T lymphocytes in old mice. Diminished production of mature c-myc RNA after mitogen exposure not attributable to alterations in transcription or RNA stability.
    Buckler AJ; Vie H; Sonenshein GE; Miller RA
    J Immunol; 1988 Apr; 140(7):2442-6. PubMed ID: 3280682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumorigenicity of SEWA murine cells correlates with degree of c-myc amplification.
    Martinsson T; Ståhl F; Pollwein P; Wenzel A; Levan A; Schwab M; Levan G
    Oncogene; 1988 Oct; 3(4):437-41. PubMed ID: 3078951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of abl and raf with IL-7 signaling pathway and transformation of pre-B cells from resistant mice.
    Hilbert DM; Theisen PW; Rudikoff EK; Bauer SR
    Oncogene; 1998 Oct; 17(16):2125-35. PubMed ID: 9798684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth of E mu-myc transgenic B-lymphoid cells in vitro and their evolution toward autonomy.
    Langdon WY; Harris AW; Cory S
    Oncogene Res; 1988; 3(3):271-9. PubMed ID: 3144697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of sodium butyrate on the rearranged c-myc expression in mouse plasmacytoma cells.
    Kondoh N; Oikawa T; Satoh C; Kuzumaki N
    Exp Cell Res; 1991 Sep; 196(1):146-9. PubMed ID: 1879469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Studies on malignancy regulation by heterologous hybridization between reticulocytes and a human plasmocytoma cell line (HMY-2)].
    Chen KQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1988 Feb; 10(1):6-13. PubMed ID: 2968181
    [No Abstract]   [Full Text] [Related]  

  • 40. Rearranged c-mos locus in a MOPC 21 murine myeloma cell line and its persistence in hybridomas.
    Gattoni-Celli S; Hsiao WL; Weinstein IB
    Nature; 1983 Dec 22-1984 Jan 4; 306(5945):795-6. PubMed ID: 6656882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.